Marktanalyse - Emergency Contraception in Norway

Value sales for emergency contraceptives increased by 1% in current value terms in 2011, a marginal gain over the previous year. Norwegian health authorities concluded the decision to make emergency contraceptives more widely available in mass distribution channels from 1 January 2009 did not impact per capita consumption. There was concern that broad distribution would move the products from an emergency solution to birth control. Norwegian health authorities were concerned that extended...

Euromonitor International's Emergency Contraception in Norway report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Emergency Contraception market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

EMERGENCY CONTRACEPTION IN NORWAY

Euromonitor International

June 2012



LIST OF CONTENTS AND TABLES



Headlines

Trends

Competitive Landscape

Prospects

Category Data

Table 1 Sales of Emergency Contraception: Value 2006-2011

Table 2 Sales of Emergency Contraception: % Value Growth 2006-2011

Table 3 Emergency Contraception Company Shares by Value 2007-2011

Table 4 Emergency Contraception Brand Shares by Value 2008-2011

Table 5 Forecast Sales of Emergency Contraception: Value 2011-2016

Table 6 Forecast Sales of Emergency Contraception: % Value Growth 2011-2016

Nycomed Pharma As in Consumer Health (norway)

Strategic Direction

Key Facts

Summary 1 Nycomed Pharma AS: Key Facts

Summary 2 Nycomed Pharma AS: Operational Indicators

Company Background

Production

Summary 3 Nycomed Pharma AS: Production Statistics 2011

Competitive Positioning

Summary 4 Nycomed Pharma AS: Competitive Position 2011

Executive Summary

Stable Growth in Value Sales for 2011

Prudent Spending Habits Emerge

Global Players Drive Competition

Important Role for Non-store Retailing

Moderate Increase Predicted

Key Trends and Developments

Consumption Declines in Spite of Rising Disposable Household Income

Multinationals Have A Bigger Role in Norway

Greater Access To Internet Adds A New Dimension To Marketing Consumer Health Products

New Products for An Ageing Population

Government-led Health Initiatives

Market Indicators

Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011

Table 8 Life Expectancy at Birth 2006-2011

Market Data

Table 9 Sales of Consumer Health by Category: Value 2006-2011

Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011

Table 11 Consumer Health Company Shares 2007-2011

Table 12 Consumer Health Brand Shares 2008-2011

Table 13 Penetration of Private Label by Category 2006-2011

Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011

Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011

Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016

Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

Appendix

OTC Registration and Classification

De-listing Or De-reimbursement

Bioequivalent/generics

Combination Products

Advertising

Packaging

Labelling

Distribution

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventative Medicine

Switches

Summary 5 OTC - Switches 2009-2011

Definitions

Sources

Summary 6 Research Sources

• Emergency Contraception in Canada
• Emergency Contraception in Denmark
• Emergency Contraception in Norway
• Emergency Contraception in Azerbaijan
• Emergency Contraception in China
• Emergency Contraception in Finland
• Emergency Contraception in Kazakhstan
• Emergency Contraception in Latvia
• Emergency Contraception in Lithuania
• Emergency Contraception in Sweden
• Emergency Contraception in the US
• Emergency Contraception in Australia
• Emergency Contraception in Uruguay
• Emergency Contraception in Kenya
• Emergency Contraception in Portugal
• Emergency Contraception in the Netherlands
• Emergency Contraception in Austria
• Emergency Contraception in Nigeria
• Emergency Contraception in Serbia
• HIV-Associated Lipodystrophy Syndrome – Pipeline Review, H2 2012